OCCIDENT — Full Portfolio

Immitra Bio develops an in-vivo stem cell therapy platform designed to treat rare genetic diseases, particularly severe inherited red blood cell disorders, by replacing complex transplants with single off-the-shelf treatments.

BiotechDeep TechMedical DevicesZürich, CH

Jan Nelis(CEO)in

Co-investorsKickfundanother.vcBackbone VenturesVenture Kick

Altavo develops non-invasive silent speech technology using RF sensing and artificial intelligence to help patients who have lost their voice regain natural-sounding speech.

AI & Machine LearningDeep TechMedical DevicesDresden, DE

Rudolf

Co-investorsNovalis Biotech

Avelo develops diagnostic technology aimed at closing the diagnostic gap in respiratory disease, so patients receive timely and accurate information for effective treatment.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsPrivilège Ventures

Chipmetrics provides 3D metrology solutions using test chips and wafers for semiconductor process control, serving semiconductor manufacturers and material developers optimizing deposition processes and yields.

Advanced ManufacturingDeep TechHardwareSemiconductors

Feng Gao(Founder)in

Co-investorsInnovestor VenturesRedstoneInnovestor

Core Sensing develops integrated wireless sensor systems that measure force, torque, and other physical quantities directly on components, delivering data to cloud platforms and dashboards for condition monitoring and predictive maintenance applications.

Advanced ManufacturingHardwareIoT

Simon Krech(Founder)in

EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software.

HealthtechMedical Devices

Giovanni Leo(Co-Founder)Douglas Packer(Co-Founder & Key Advisor)Ugo Amaldi(Co-Founder & Key Advisor)Marina Izzo(Chief Executive Officer & Director)inAdriano Garonna(Chief Technology Officer)inOlivier Coquoz(Head of R&D)

Co-investorsElysia CapitalLIFTT

hemotune develops a magnetic nanoparticle platform for targeted magnetic separation in medical and biomanufacturing applications.

BiotechDeep TechMedical Devices

Hannover, DE

Co-investorsEnjoyventure Management

iMusician is a music distribution and artist management platform that enables independent musicians and labels to upload, distribute, and monetize their music across global streaming platforms.

B2B MarketplacesCreator EconomyMedia & EntertainmentSaaSGeneva, CH

Tobias Wirz(Founder)in

Startup that credited Venture Kick with helping establish its customer and market focus.

Co-investorsSICTICVenture Kick

Lunaphore develops spatial biology solutions that enable scientists and clinicians to analyze tissue structure and cellular composition.

BiotechDeep TechMedical DevicesLausanne, CH

Co-investorsPolytech Ecosystem VenturesZühlke Ventures

Co-investorsCDP Venture Capital

ReCatalyst develops a nanotechnology catalyst platform aimed at reducing dependency on scarce platinum group metals, starting with carbon-supported platinum-based catalysts for hydrogen technologies like fuel cells and water electrolysers.

CleantechDeep TechNew Materials

Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings.

BiotechHealthtechMedical Devices

Dr. Danuta Cichocka(CEO, Co-Founder, Board Member)inGrzegorz Gonciarz(COO)inDr. Alex Sturm(Chief Scientific Officer)inMartin Birk(CFO)in

Co-investorsAlpana VenturesTRUMPF Venture

StartupTicker is a Swiss platform that maintains a public database of over 200 venture capitalists, business angel clubs, and corporate venture funds that have invested in Swiss startups.

Media & EntertainmentSector AgnosticSwitzerland, CH

Co-investorsSICTIC

Thermosome is a drug development company working on targeted tumor therapy combined with immune stimulation, using a tumor targeting approach designed to increase local drug concentrations for better treatment outcomes in cancer patients.

BiotechHealthtech

Co-investorsBayern Kapital

The page is a placeholder shell showing only cookie/consent notices for embedded third-party content (Vimeo, YouTube, reCAPTCHA, social media) and contains no substantive information about the company.

Dominik Schumacher(Founder)in

Co-investorsAndera PartnersBioMedPartnersFrazier Life SciencesFund+Nextech Invest

GENFIT is a biopharmaceutical company developing therapies for rare, life-threatening liver diseases, with a focus on acute-on-chronic liver failure (ACLF), hepatic encephalopathy (HE), cholangiocarcinoma, urea cycle disorders, and organic acidemias.

BiotechDigital HealthMedical Devices

Co-investorsVerve Ventures